Song Y, Zhang J, Li Y, Cheng L, Song H, Zhang Y
Int J Mol Sci. 2024; 25(23).
PMID: 39684684
PMC: 11640967.
DOI: 10.3390/ijms252312974.
Ouissam A, Hind C, Sami Aziz B, Said A
Ther Adv Med Oncol. 2024; 16:17588359241284911.
PMID: 39399412
PMC: 11468005.
DOI: 10.1177/17588359241284911.
Park E, Hwang Y, Ryu H, Yoon H, Kim J, Lim J
Front Pharmacol. 2024; 15:1439079.
PMID: 39295927
PMC: 11408334.
DOI: 10.3389/fphar.2024.1439079.
Zhang Y, Zhang M, Wu H, Wu X, Zheng H, Feng J
J Virol. 2024; 98(9):e0068524.
PMID: 39162435
PMC: 11406966.
DOI: 10.1128/jvi.00685-24.
Pesini C, Artal L, Paul Bernal J, Sanchez Martinez D, Pardo J, Ramirez-Labrada A
Oncoimmunology. 2024; 13(1):2379062.
PMID: 39036370
PMC: 11259085.
DOI: 10.1080/2162402X.2024.2379062.
LILRB1-HLA-G axis defines a checkpoint driving natural killer cell exhaustion in tuberculosis.
Wang J, Chai Q, Lei Z, Wang Y, He J, Ge P
EMBO Mol Med. 2024; 16(8):1755-1790.
PMID: 39030302
PMC: 11319715.
DOI: 10.1038/s44321-024-00106-1.
Lacticaseibacillus casei K11 exerts immunomodulatory effects by enhancing natural killer cell cytotoxicity via the extracellular regulated-protein kinase pathway.
Zhou Y, Kuerman M, Zhou Q, Hou B, Li B, Li Y
Eur J Nutr. 2024; 63(5):1867-1876.
PMID: 38592520
DOI: 10.1007/s00394-024-03390-2.
Autologous T-Cell-Free Antigen Presentation System Unveils hCMV-Specific NK Cell Response.
Ustiuzhanina M, Streltsova M, Timofeev N, Kryukov M, Chudakov D, Kovalenko E
Cells. 2024; 13(6.
PMID: 38534374
PMC: 10969127.
DOI: 10.3390/cells13060530.
Scalable nonparametric clustering with unified marker gene selection for single-cell RNA-seq data.
Nwizu C, Hughes M, Ramseier M, Navia A, Shalek A, Fusi N
bioRxiv. 2024; .
PMID: 38405697
PMC: 10888887.
DOI: 10.1101/2024.02.11.579839.
Combined use of NK cells and radiotherapy in the treatment of solid tumors.
Zheng W, Ling S, Cao Y, Shao C, Sun X
Front Immunol. 2024; 14:1306534.
PMID: 38264648
PMC: 10803658.
DOI: 10.3389/fimmu.2023.1306534.
Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond.
Shin E, Bak S, Park T, Kim J, Yoon S, Jung H
Front Immunol. 2023; 14:1192907.
PMID: 37539051
PMC: 10395517.
DOI: 10.3389/fimmu.2023.1192907.
McSNAC: A software to approximate first-order signaling networks from mass cytometry data.
Wethington D, Mukherjee S, Das J
Quant Biol. 2023; 11(1):59-71.
PMID: 37123637
PMC: 10134772.
DOI: 10.15302/j-qb-022-0308.
CD160 receptor in CLL: Current state and future avenues.
Oumeslakht L, Aziz A, Bensussan A, Ben Mkaddem S
Front Immunol. 2022; 13:1028013.
PMID: 36420268
PMC: 9676924.
DOI: 10.3389/fimmu.2022.1028013.
IL-2 Combined with IL-15 Enhanced the Expression of NKG2D Receptor on Patient Autologous NK Cells to Inhibit Wilms' Tumor via MAPK Signaling Pathway.
Li Y, Li Y, Xiang B, Tian X, Shi Q, Liu F
J Oncol. 2022; 2022:4544773.
PMID: 36213822
PMC: 9546681.
DOI: 10.1155/2022/4544773.
Akt isoforms in the immune system.
Guerau-de-Arellano M, Piedra-Quintero Z, Tsichlis P
Front Immunol. 2022; 13:990874.
PMID: 36081513
PMC: 9445622.
DOI: 10.3389/fimmu.2022.990874.
Delivery of human natural killer cell-derived exosomes for liver cancer therapy: an in vivo study in subcutaneous and orthotopic animal models.
Kim H, Min H, Song H, Yoo A, Lee S, Kim K
Drug Deliv. 2022; 29(1):2897-2911.
PMID: 36068970
PMC: 9467548.
DOI: 10.1080/10717544.2022.2118898.
Screening for Active Compounds Targeting Human Natural Killer Cell Activation Identifying Daphnetin as an Enhancer for IFN-γ Production and Direct Cytotoxicity.
Yao B, Yang Q, Yang Y, Li Y, Peng H, Wu S
Front Immunol. 2021; 12:680611.
PMID: 34956168
PMC: 8693168.
DOI: 10.3389/fimmu.2021.680611.
Epigenetic regulation of natural killer cell memory.
Lau C, Wiedemann G, Sun J
Immunol Rev. 2021; 305(1):90-110.
PMID: 34908173
PMC: 8955591.
DOI: 10.1111/imr.13031.
Siglec-8 Signals Through a Non-Canonical Pathway to Cause Human Eosinophil Death .
Carroll D, Cao Y, Bochner B, OSullivan J
Front Immunol. 2021; 12:737988.
PMID: 34721399
PMC: 8549629.
DOI: 10.3389/fimmu.2021.737988.
PI3K/Akt Pathway: The Indestructible Role of a Vintage Target as a Support to the Most Recent Immunotherapeutic Approaches.
Caforio M, de Billy E, De Angelis B, Iacovelli S, Quintarelli C, Paganelli V
Cancers (Basel). 2021; 13(16).
PMID: 34439194
PMC: 8392360.
DOI: 10.3390/cancers13164040.